ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

Marijuana-Derived Drug Less Effective Than Standard

March 29, 2002

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

Harkin, Bumpers Concerned Over Centers Funding

May 5, 1989

NCS Group Asks DRG Adjustments For Institutions With Peer reviewed Components, 25 Protocol Patients

July 1, 1983

House Appropriations Adds $20 Mil. To Bush Request For NCI, Emphasizes Three Cancers

June 28, 1991

NCCS Networker Volume 4 Issue 1, Winter 1990

January 13, 1990